GKHT Medical Technology Co., Ltd. (SHE:301370)
China flag China · Delayed Price · Currency is CNY
8.68
-0.06 (-0.69%)
Oct 8, 2026, 4:00 PM EDT

GKHT Medical Technology Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Revenue
6,4266,9407,3037,4466,3275,814
Other Revenue
46.4347.0843.3436.8132.632.9
6,4736,9877,3467,4836,3605,847
Revenue Growth
-12.13%-4.89%-1.82%17.66%8.76%20.27%
Cost of Revenue
5,8936,3246,5796,6265,5365,043
Gross Profit
579.71663.09767.52856.87823.84804.55
Selling, General & Admin
480.52509.28514.73513.18442.53386.44
Research & Development
13.7910.3510.9512.912.410.55
Other Operating Expenses
22.322.122119.2519.4719.2
Operating Expenses
517.89537.17537.8530.41501.53440.1
Operating Income
61.83125.92229.72326.46322.32364.45
Interest Expense
-30.3-34.35-60.95-88.18-119.32-128.96
Interest & Investment Income
2.844.336.345.623.182.85
Currency Exchange Gain (Loss)
-0.02-0.01-0.07-0.1-0.280.18
Other Non Operating Income (Expenses)
-13.19-20.47-5.59-8.37-19.32-8.46
EBT Excluding Unusual Items
21.1675.42169.45235.43186.58230.07
Gain (Loss) on Sale of Investments
-2.24-2.49-0.52-4.99--
Gain (Loss) on Sale of Assets
0.010.12-0.21-0.180.22-0.03
Asset Writedown
-0.16-0.59-0.07-0.81-0.220.01
Other Unusual Items
28.2619.7420.226.639.2311.78
Pretax Income
47.0492.21188.86236.08195.81241.84
Income Tax Expense
30.7627.6137.1365.3753.7162
Earnings From Continuing Operations
16.2864.6151.74170.71142.1179.84
Minority Interest in Earnings
10.483.55-21.07-16.83-17.19-28.63
Net Income
26.7668.15130.66153.88124.91151.21
Net Income to Common
26.7668.15130.66153.88124.91151.21
Net Income Growth
-77.67%-47.84%-15.09%23.19%-17.39%3.55%
Shares Outstanding (Basic)
518487467427403398
Shares Outstanding (Diluted)
518487467427403398
Shares Change
12.18%4.31%9.17%6.08%1.26%0.83%
EPS (Basic)
0.050.140.280.360.310.38
EPS (Diluted)
0.050.140.280.360.310.38
EPS Growth
-80.09%-50.00%-22.22%16.13%-18.42%2.70%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
438.09646.05606.32562.37214.1145.78
Free Cash Flow Per Share
0.851.331.301.320.530.37
Dividend Per Share
0.1220.1220.0840.118--
Dividend Growth
45.24%45.24%-28.81%---
Gross Margin
8.96%9.49%10.45%11.45%12.95%13.76%
Operating Margin
0.95%1.80%3.13%4.36%5.07%6.23%
Profit Margin
0.41%0.97%1.78%2.06%1.96%2.59%
Free Cash Flow Margin
6.77%9.25%8.25%7.51%3.37%2.49%
EBITDA
85.42159.76286.95368.63363.89391.73
EBITDA Margin
1.32%2.29%3.91%4.93%5.72%6.70%
D&A For EBITDA
23.633.8457.2342.1741.5727.28
EBIT
61.83125.92229.72326.46322.32364.45
EBIT Margin
0.95%1.80%3.13%4.36%5.07%6.23%
Effective Tax Rate
65.39%29.95%19.66%27.69%27.43%25.64%
Revenue as Reported
6,4736,9877,3467,4836,360-